Pharmacokinetic analysis and simplified uptake measures for tumour lesion [18F]F-AraG PET imaging in patients with non-small cell lung cancer
Tumour lesion [<sup>18</sup>F]F-AraG uptake in patients with NSCLC is characterised by a 2T3k model. TBR and TPR show most potential for simplified quantification of tumour lesion [<sup>18</sup>F]F-AraG uptake in patients with NSCLC.
Authors
- Robert C. Schuit (ORCID: https://orcid.org/0000-0002-4962-2367)
- Chris Dickhoff (ORCID: https://orcid.org/0000-0002-6396-8372)
- Albert D. Windhorst (ORCID: https://orcid.org/0000-0002-1250-7656)
- Maarten Slebe (ORCID: https://orcid.org/0000-0001-8056-1235)
- Johanna E. E. Pouw (ORCID: https://orcid.org/0000-0003-1358-1804)
- Andrea Thiele
- Maqsood Yaqub
- Ronald Boellaard (ORCID: https://orcid.org/0000-0002-0313-5686)
- Daniela E. Oprea-Lager
- Jessica E. Wijngaarden (ORCID: https://orcid.org/0000-0003-1486-6246)
- Jelena Levi (ORCID: https://orcid.org/0000-0002-0846-0795)
- Idris Bahce (ORCID: https://orcid.org/0000-0002-1111-608X)
- C. Willemien Menke‐van der Houven van Oordt (ORCID: https://orcid.org/0000-0002-5404-5883)
Institutions
- Boehringer Ingelheim (Germany) (DE)
- Dutch Cancer Society (NL)
- Amsterdam Neuroscience (NL)
- CellSight Technologies (United States) (US)
- Amsterdam University Medical Centers (NL)
- Cancer Center Amsterdam (NL)
- Vrije Universiteit Amsterdam (NL)
Publication Details
- Journal
- European Journal of Nuclear Medicine and Molecular Imaging
- Published
- 2024-10-08
- DOI
- https://doi.org/10.1007/s00259-024-06931-3
- Citations
- 1
- Primary Topic
- Medical Imaging Techniques and Applications
- Type
- article
- Field-Weighted Citation Impact
- 0.40
Funders
- Boehringer Ingelheim